Short answer
Align Technology (ALGN) filed its Q3 2026 10-Q quarterly report on Nov 4, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $1.0B (up 1.9% year over year) with net income of $135M.
Q3 2026 key financials · XBRL
- Revenue
- $1.0B
- +1.9% YoY · −3.9% QoQ
- Net income
- $135M
- +138.0% YoY · +24.7% QoQ
- Operating margin
- 16.7%
- Gross margin
- 68.7%
- EPS (diluted)
- $1.89
- +139.2% YoY · +24.3% QoQ
Source: XBRL data from the Align Technology (ALGN) Q3 2026 10-Q on SEC EDGAR. USD.
Align Technology Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $1,014.8M, up 1.9% YoY from $995.7M
- Clear Aligners best segment: $839.3M, up 4.2% YoY; Systems and Services $175.5M, down 7.6%
- Operating margin 16.7% vs 9.7% YoY; gross margin 68.7% vs 64.2%
- Cash $1,145M; operating cash flow $183M; capital expenditures $45M; share repurchases $201.2M year-to-date
- Headwinds: tariffs, macroeconomic uncertainty, lower ASPs, unfavorable foreign exchange, UK VAT liability $43.1M
Risk Factors
- New regulatory risk: European Commission formal competition investigation announced June 29, 2026, covering Invisalign and iTero practices
- Most material trade update: Section 301 duties on imports from 60 U.S. trade partners began July 24, 2026, without a fixed expiration date
- Compliance risk: FDA Quality Management System Regulation became effective February 2, 2026, adding inspection and enforcement exposure
- Near-term market risk: Intensifying competition, including AI-enabled dental technologies and lower-priced clear aligners
- Financial risk: Foreign-currency fluctuations affecting international revenues, expenses, results of operations and cash flows
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Align Technology quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.